Generation of atypical pulmonary inflammatory responses in BALB/c mice after immunization with the native attachment (G) glycoprotein of respiratory syncytial virus

No abstract is available for this paper.

• Publication year

  1996

• Venue

  Journal of Virology

• Publication date

  1996-11-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1128/jvi.70.11.7783-7791.1996PMID 8892899PMCID PMC190848
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• IFN-gamma and IL-4 regulate the growth and differentiation of CD8+ T cells into subpopulations with distinct cytokine profiles.

  1995cited by this paper
• Cytokine-induced differentiation of precursor mouse CD8+ T cells into cytotoxic CD8+ T cells secreting Th1 or Th2 cytokines.

  1995cited by this paper
• Formulation of the purified fusion protein of respiratory syncytial virus with the saponin QS-21 induces protective immune responses in Balb/c mice that are similar to those generated by experimental infection.

  1995cited by this paper
• Production of IL-5 by human NK cells and regulation of IL-5 secretion by IL-4, IL-10, and IL-12.

  1995cited by this paper
• Enhanced pulmonary histopathology induced by respiratory syncytial virus (RSV) challenge of formalin-inactivated RSV-immunized BALB/c mice is abrogated by depletion of interleukin-4 (IL-4) and IL-10

  1994cited by this paper
• Interleukin 5 synthesis by eosinophils: association with granules and immunoglobulin-dependent secretion

  1994cited by this paper
• Impact of the saponin adjuvant QS-21 and aluminium hydroxide on the immunogenicity of recombinant OspA and OspB of Borrelia burgdorferi.

  1994cited by this paper
• Interleukin-12: a cytokine produced by antigen-presenting cells with immunoregulatory functions in the generation of T-helper cells type 1 and cytotoxic lymphocytes.

  1994cited by this paper
• The pulmonary immune response of Balb/c mice vaccinated with the fusion protein of respiratory syncytial virus.

  1994cited by this paper
• Distinct types of lung disease caused by functional subsets of antiviral T cells

  1994influential reference
• An update on approaches to the development of respiratory syncytial virus (RSV) and parainfluenza virus type 3 (PIV3) vaccines.

  1994cited by this paper
• Eosinophil cationic protein in nasopharyngeal secretions and serum of infants infected with respiratory syncytial virus

  1994cited by this paper
• Immunogenicity and safety of respiratory syncytial virus subunit vaccine in seropositive children 18-36 months old.

  1993cited by this paper
• Enhanced pulmonary pathology associated with the use of formalin-inactivated respiratory syncytial virus vaccine in cotton rats is not a unique viral phenomenon.

  1993cited by this paper
• Priming immunization determines T helper cytokine mRNA expression patterns in lungs of mice challenged with respiratory syncytial virus.

  1993cited by this paper
• Phenotypic and functional characterization of T cell lines specific for individual respiratory syncytial virus proteins.

  1993influential reference
• A human respiratory syncytial virus (RSV) primate model of enhanced pulmonary pathology induced with a formalin-inactivated RSV vaccine but not a recombinant FG subunit vaccine.

  1993cited by this paper
• Human cytotoxic T cells stimulated by antigen on dendritic cells recognize the N, SH, F, M, 22K, and 1b proteins of respiratory syncytial virus

  1992cited by this paper
• Activation of Human Eosinophils In Vitro by Respiratory Syncytial Virus

  1992cited by this paper
• Saponin adjuvant induction of ovalbumin-specific CD8+ cytotoxic T lymphocyte responses.

  1992cited by this paper
• Eosinophil degranulation in the respiratory tract during naturally acquired respiratory syncytial virus infection.

  1992cited by this paper
• Cotton rats previously immunized with a chimeric RSV FG glycoprotein develop enhanced pulmonary pathology when infected with RSV, a phenomenon not encountered following immunization with vaccinia--RSV recombinants or RSV.

  1992cited by this paper
• Pulmonary histopathology induced by respiratory syncytial virus (RSV) challenge of formalin-inactivated RSV-immunized BALB/c mice is abrogated by depletion of CD4+ T cells

  1992cited by this paper
• Serious respiratory tract disease caused by respiratory syncytial virus: prospects for improved therapy and effective immunization.

  1992influential reference
• Immunity to and frequency of reinfection with respiratory syncytial virus.

  1991influential reference
• Protection of BALB/c mice from respiratory syncytial virus infection by immunization with a synthetic peptide derived from the G glycoprotein.

  1991cited by this paper
• Vaccination against respiratory syncytial virus: problems and progress.

  1991cited by this paper
• Differing lymphokine profiles of functional subsets of human CD4 and CD8 T cell clones.

  1991cited by this paper
• Separation and characterization of saponins with adjuvant activity from Quillaja saponaria Molina cortex.

  1991cited by this paper
• Diversity of Cytokine Synthesis and Function of Mouse CD4+ T Cells

  1991cited by this paper
• Group-specific serum antibody responses in children with primary and recurrent respiratory syncytial virus infections.

  1991influential reference
• A chimeric glycoprotein of human respiratory syncytial virus termed FG induces T-cell mediated immunity in mice.

  1991cited by this paper
• Antigenic and genomic diversity within group A respiratory syncytial virus.

  1991cited by this paper
• Antibody to interleukin-5 inhibits helminth-induced eosinophilia in mice.

  1989cited by this paper
• Genetic control of eosinophilia. Analysis of production and response to eosinophil-differentiating factor in strains of mice infected with Trichinella spiralis.

  1989cited by this paper
• The G glycoprotein of human respiratory syncytial viruses of subgroups A and B: extensive sequence divergence between antigenically related proteins.

  1987cited by this paper
• A sensitive immunochemical assay for biologically active MuIFN-gamma.

  1987cited by this paper
• Effect of age and preexisting antibody on serum antibody response of infants and children to the F and G glycoproteins during respiratory syncytial virus infection

  1986cited by this paper
• Dissociation between serum neutralizing and glycoprotein antibody responses of infants and children who received inactivated respiratory syncytial virus vaccine

  1986cited by this paper
• Respiratory syncytial virus. Brief review.

  1985cited by this paper
• Respiratory syncytial virus envelope glycoprotein (G) has a novel structure.

  1985cited by this paper
• Enzyme amplification can enhance both the speed and the sensitivity of immunoassays.

  1985cited by this paper
• Purification and characterization of GP90, one of the envelope glycoproteins of respiratory syncytial virus.

  1984cited by this paper
• Monoclonal antibody to murine gamma interferon inhibits lymphokine- induced antiviral and macrophage tumoricidal activities

  1984cited by this paper
• Monoclonal antibodies protect against respiratory syncytial virus infection in mice.

  1984cited by this paper
• Protection from respiratory syncytial virus infection in cotton rats by passive transfer of monoclonal antibodies

  1984cited by this paper
• Parenteral administration of live respiratory syncytial virus vaccine: results of a field trial.

  1982cited by this paper
• The Development of Balb/c Cells Persistently Infected with Respiratory Syncytial Virus: Presence of Ribonucleoprotein on the Cell Surface 1

  1981cited by this paper
• Cell-mediated Immunity to Respiratory Syncytial Virus Induced by Inactivated Vaccine or by Infection

  1976cited by this paper
• Safety and antigenicity of temperature sensitive (TS) mutant respiratory syncytial virus (RSV) in infants and children.

  1973cited by this paper
• Clinical and immunological response of infants and children to administration of low-temperature adapted respiratory syncytial virus.

  1971cited by this paper
• An epidemiologic study of altered clinical reactivity to respiratory syncytial (RS) virus infection in children previously vaccinated with an inactivated RS virus vaccine.

  1969influential reference
• Respiratory syncytial virus disease in infants despite prior administration of antigenic inactivated vaccine.

  1969influential reference
• ACUTE RESPIRATORY DISEASE IN INFANCY AND CHILDHOOD: PRESENT UNDERSTANDING AND PROSPECTS FOR PREVENTION.

  1965cited by this paper

• Respiratory Syncytial Virus F Protein Adjuvanted with a Carbomer-Based Adjuvant Induces Protective Humoral Response in Mice

  2026cites this paper
• Restricting O-Linked Glycosylation of the Mucin-like Domains Enhances Immunogenicity and Protective Efficacy of a Respiratory Syncytial Virus G Glycoprotein Vaccine Antigen

  2025cites this paper
• Intranasal Vaccination with a Respiratory-Syncytial-Virus-Based Virus-like Particle Displaying the G Protein Conserved Region Induces Severe Weight Loss and Pathology upon Challenge with Wildtype Respiratory Syncytial Virus

  2024cites this paper
• Recombinant RSV G protein vaccine induces enhanced respiratory disease via IL-13 and mucin overproduction

  2024cites this paper
• Non-glycosylated G protein with CpG ODN provides robust protection against respiratory syncytial virus without inducing eosinophilia

  2023cites this paper
• Vaccine-Associated Enhanced Disease and Pathogenic Human Coronaviruses

  2022cites this paper
• Immunopathology of RSV: An Updated Review

  2021cites this paper
• Role of CCR3 in respiratory syncytial virus infection of airway epithelial cells

  2021cites this paper
• Contribution of Dendritic Cells in Protective Immunity against Respiratory Syncytial Virus Infection

  2020cites this paper
• Learning from the past: development of safe and effective COVID-19 vaccines

  2020cites this paper
• Impact of Respiratory Syncytial Virus Infection on the Host Cell: Implications for Antiviral Strategies.

  2020cites this paper
• Respiratory syncytial virus subunit vaccines based on the viral envelope glycoproteins intended for pregnant women and the elderly

  2019cites this paper
• Immunological Lessons from Respiratory Syncytial Virus Vaccine Development.

  2019cites this paper
• Multiple Isoforms of Anti-Lipopolysaccharide Factors and Their Antimicrobial Functions in the Ridgetail Prawn Exopalaemon carinicauda

  2018cites this paper
• Identification and function analysis of an anti‐lipopolysaccharide factor from the ridgetail prawn Exopalaemon carinicauda

  2017cites this paper
• Monoclonal Antibody against G Glycoprotein Increases Respiratory Syncytial Virus Clearance In Vivo and Prevents Vaccine-Enhanced Diseases

  2017cites this paper
• Modulation of the host immune response by respiratory syncytial virus proteins

  2017cites this paper
• Universal vaccine against respiratory syncytial virus A and B subtypes

  2017cites this paper
• Characteristics of RSV-Specific Maternal Antibodies in Plasma of Hospitalized, Acute RSV Patients under Three Months of Age

  2017cites this paper
• Preclinical evaluation of bacterially produced RSV-G protein vaccine: Strong protection against RSV challenge in cotton rat model

  2017cites this paper
• Host-pathogens interactions during RSV / S. pneumoniae infection immune response and p53 pathway

  2017cites this paper
• Chimeric virus-like particles containing a conserved region of the G protein in combination with a single peptide of the M2 protein confer protection against respiratory syncytial virus infection.

  2016cites this paper
• respiratory syncytial virus disease

  2015cites this paper
• Enhanced immunogenicity of a respiratory syncytial virus (RSV) F subunit vaccine formulated with the adjuvant GLA-SE in cynomolgus macaques.

  2015cites this paper
• Recombinant influenza virus carrying the conserved domain of respiratory syncytial virus (RSV) G protein confers protection against RSV without inflammatory disease.

  2015cites this paper
• Brief History and Characterization of Enhanced Respiratory Syncytial Virus Disease

  2015cites this paper
• Nonglycosylated G-Protein Vaccine Protects against Homologous and Heterologous Respiratory Syncytial Virus (RSV) Challenge, while Glycosylated G Enhances RSV Lung Pathology and Cytokine Levels

  2015cites this paper
• Monoclonal Antibodies Against the Human Respiratory Syncytial Virus Obtained by Immunization with Epitope Peptides and CpG-DNA-liposome Complex

  2015cites this paper
• Cross-resistance mechanism of respiratory syncytial virus against structurally diverse entry inhibitors

  2014cites this paper
• Development of a reverse genetics system for respiratory syncytial virus long strain and an immunogenicity study of the recombinant virus

  2014cites this paper
• Prevention of Respiratory Syncytial Virus Infection: From Vaccine to Antibody

  2014cites this paper
• Effects of Toll-like Receptor Stimulation on Eosinophilic Infiltration in Lungs of BALB/c 1

  2014cites this paper
• Effects of Toll-Like Receptor Stimulation on Eosinophilic Infiltration in Lungs of BALB/c Mice Immunized with UV-Inactivated Severe Acute Respiratory Syndrome-Related Coronavirus Vaccine

  2014cites this paper
• Mapping of CD8 T Cell Epitopes in Human Respiratory Syncytial Virus L Protein

  2014cites this paper
• The N500 Glycan of the Respiratory Syncytial Virus F Protein is Required for Fusion, but Not for Stabilization or Triggering of the Protein

  2013cites this paper
• Non-propagating, recombinant vesicular stomatitis virus vectors encoding respiratory syncytial virus proteins generate potent humoral and cellular immunity against RSV and are protective in mice.

  2013cites this paper
• A Respiratory Syncytial Virus (RSV) Anti-G Protein F(ab′)2 Monoclonal Antibody Suppresses Mucous Production and Breathing Effort in RSV rA2-line19F-Infected BALB/c Mice

  2013cites this paper
• Protective and dysregulated T cell immunity in RSV infection

  2013cites this paper
• Respiratory Syncytial Virus G Protein CX3C Motif Impairs Human Airway Epithelial and Immune Cell Responses

  2013cites this paper
• Understanding respiratory syncytial virus infection to improve treatment and immunity.

  2013cites this paper
• virus (RSV) vaccination model but does not adversely affect humoral responses in a respiratory syncytial B-cell depletion inhibits arthritis in a collagen-induced arthritis (CIA) model

  2013cites this paper
• Decrease in Formalin-Inactivated Respiratory Syncytial Virus (FI-RSV) Enhanced Disease with RSV G Glycoprotein Peptide Immunization in BALB/c Mice

  2013cites this paper
• Nonreplicating vaccines can protect african green monkeys from the memphis 37 strain of respiratory syncytial virus.

  2013cites this paper
• Negative Effect on CD8+ T Cell Memory Clearance of Sendai Virus in Mice, but Has a CD4+ T Cell Priming Accelerates the

  2013cites this paper
• Experimental SARS and influenza: similar disease, different pathways

  2013cites this paper
• Targeting RSV with vaccines and small molecule drugs.

  2012cites this paper
• Mechanisms of resistance for human respiratory syncytial virus isolates against anti-fusion agents in tissue culture

  2012cites this paper
• Respiratory syncytial virus infection and immunity

  2012cites this paper
• Baculovirus-based Vaccine Displaying Respiratory Syncytial Virus Glycoprotein Induces Protective Immunity against RSV Infection without Vaccine-Enhanced Disease

  2012cites this paper
• Need for a safe vaccine against respiratory syncytial virus infection

  2012cites this paper
• Neonatal vaccination against respiratory syncytial virus infection

  2012cites this paper
• Dual Role of Respiratory Syncytial Virus Glycoprotein Fragment as a Mucosal Immunogen and Chemotactic Adjuvant

  2012cites this paper
• Avaliação da resposta imune contra as proteínas L e G do vírus respiratório sincicial humano.

  2012cites this paper
• The innate immune mechanisms underlying the interplay between respiratory infections and asthma

  2011cites this paper
• Dynamics of the bacterially expressed conserved immunogenic region of the human respiratory syncytial virus G protein

  2011cites this paper
• Effects of respiratory syncytial virus infection and major basic protein derived from eosinophils in pulmonary alveolar epithelial cells (A549)

  2011cites this paper
• Complement C3a and Tachykinins Hyperreponsiveness through Regulation by Syncytial Virus-Associated Airway Th17 Cytokines Are Critical for Respiratory

  2011cites this paper
• Current progress on development of respiratory syncytial virus vaccine.

  2011cites this paper
• Th17 Cytokines Are Critical for Respiratory Syncytial Virus-Associated Airway Hyperreponsiveness through Regulation by Complement C3a and Tachykinins

  2011cites this paper
• Recombinant Live Vaccines to Protect Against the Severe Acute Respiratory Syndrome Coronavirus

  2010cites this paper
• Pneumovirus and Metapneumovirus: Respiratory Syncytial Virus and Human Metapneumovirus

  2010cites this paper
• TLR9 agonist, but not TLR7/8, functions as an adjuvant to diminish FI-RSV vaccine-enhanced disease, while either agonist used as therapy during primary RSV infection increases disease severity.

  2009cites this paper
• Protective Efficacy and Immunogenicity of an Adenoviral Vector Vaccine Encoding the Codon-Optimized F Protein of Respiratory Syncytial Virus

  2009cites this paper
• Newcastle Disease Virus-Like Particles Containing Respiratory Syncytial Virus G Protein Induced Protection in BALB/c Mice, with No Evidence of Immunopathology

  2009cites this paper
• Respiratory Syncytial Virus (RSV) Induces Innate Immunity through Toll-Like Receptors and Acquired Immunity via the RSV G Protein: A Dissertation

  2009cites this paper
• Murine host responses to respiratory syncytial virus (RSV) following intranasal administration of a Protollin-adjuvanted, epitope-enhanced recombinant G protein vaccine.

  2009cites this paper
• Vaccines for Severe Acute Respiratory Syndrome Virus and Other Coronaviruses

  2008cites this paper
• Pulmonary eosinophilia requires interleukin‐5, eotaxin‐1, and CD4+ T cells in mice immunized with respiratory syncytial virus G glycoprotein

  2008cites this paper
• Sendai virus recombinant vaccine expressing hPIV-3 HN or F elicits protective immunity and combines with a second recombinant to prevent hPIV-1, hPIV-3 and RSV infections.

  2008cites this paper
• Human and bovine respiratory syncytial virus vaccine research and development.

  2008cites this paper
• Host immunity during RSV pathogenesis.

  2008cites this paper
• Immunopathology of RSV infection: prospects for developing vaccines without this complication

  2007cites this paper
• Alphavirus replicon particles encoding the fusion or attachment glycoproteins of respiratory syncytial virus elicit protective immune responses in BALB/c mice and functional serum antibodies in rhesus macaques.

  2007cites this paper
• Immunogenicity and efficacy of codon optimized DNA vaccines encoding the F-protein of respiratory syncytial virus.

  2007cites this paper
• Venezuelan Equine Encephalitis Virus Replicon Particles Encoding Respiratory Syncytial Virus Surface Glycoproteins Induce Protective Mucosal Responses in Mice and Cotton Rats

  2007cites this paper
• Infection expérimentale par le virus respiratoire syncytial bovin : étude des interactions entre la vaccination et l'évolution du virus

  2007cites this paper
• C57Bl/6 mice are protected from respiratory syncytial virus (RSV) challenge and IL-5 associated pulmonary eosinophilic infiltrates following intranasal immunization with Protollin-eRSV vaccine.

  2007cites this paper
• Single Intranasal Immunization with Recombinant Adenovirus-Based Vaccine Induces Protective Immunity against Respiratory Syncytial Virus Infection

  2007cites this paper
• Caractérisation de la pathogenèse associée à l'infection par le métapneumovirus humain (HMPV) et évaluation de modalités prophylactiques et thérapeutiques

  2007influential citation
• Understanding respiratory syncytial virus (RSV) vaccine-enhanced disease

  2007cites this paper
• Mice and Cotton Rats Induce Protective Mucosal Responses in Syncytial Virus Surface Glycoproteins Replicon Particles Encoding Respiratory Venezuelan Equine Encephalitis Virus

  2007cites this paper
• Vaccines to prevent severe acute respiratory syndrome coronavirus-induced disease

  2007cites this paper
• Genetic approaches to the study of coronavirus replication and pathogenesis

  2007influential citation
• Respiratory syncytial virus (RSV) evades the human adaptive immune system by skewing the Th1/Th2 cytokine balance toward increased levels of Th2 cytokines and IgE, markers of allergy—a review

  2006cites this paper
• Oral immunogenicity of a plant-made, subunit, tuberculosis vaccine.

  2006cites this paper
• The TLR4 agonist, monophosphoryl lipid A, attenuates the cytokine storm associated with respiratory syncytial virus vaccine-enhanced disease.

  2006cites this paper
• Protection against Respiratory Syncytial Virus by a Recombinant Newcastle Disease Virus Vector

  2006cites this paper
• Respiratory syncytial virus: immunopathology and control

  2006cites this paper
• The role of innate immunity in protection against respiratory syncytial virus (RSV).

  2006cites this paper
• Immunology of RSV

  2006cites this paper
• Vaccine Efficacy in Senescent Mice Challenged with Recombinant SARS-CoV Bearing Epidemic and Zoonotic Spike Variants

  2006influential citation
• Short title: Effect of B cell depletion in CIA and RSV models

  2005cites this paper
• Formulation with CpG Oligodeoxynucleotides Prevents Induction of Pulmonary Immunopathology following Priming with Formalin-Inactivated or Commercial Killed Bovine Respiratory Syncytial Virus Vaccine

  2005cites this paper
• The role of reverse genetics in the development of vaccines against respiratory viruses

  2005cites this paper
• Carriers for the delivery of a vaccine against respiratory syncytial virus

  2005cites this paper
• B-cell depletion inhibits arthritis in a collagen-induced arthritis (CIA) model, but does not adversely affect humoral responses in a respiratory syncytial virus (RSV) vaccination model.

  2005cites this paper
• Cytokines and respiratory syncytial virus infection.

  2005cites this paper
• DNA vaccination against respiratory syncytial virus in young calves.

  2005cites this paper
• Modulation of Protective Immunity, Eosinophilia, and Cytokine Responses by Selective Mutagenesis of a Recombinant G Protein Vaccine against Respiratory Syncytial Virus

  2005cites this paper
• Vβ14+ T Cells Mediate the Vaccine-Enhanced Disease Induced by Immunization with Respiratory Syncytial Virus (RSV) G Glycoprotein but Not with Formalin-Inactivated RSV

  2004influential citation